Spero Therapeutics, Inc. SEC filings SPRO

Spero Therapeutics, Inc. has 515 filings in SEC EDGAR's recent list, going back to Mar 21, 2017. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change). The company's fiscal year ends on December 31.

Spero Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 27, 2026 Oct 26, 2026
8-K Current report
Material agreement, Other events
Aug 28, 2026 Aug 28, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Jul 14, 2026 Jul 8, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Jun 25, 2026 Jun 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 22, 2026 Jun 17, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
8-K Current report
Results of operations
Mar 26, 2026 Mar 26, 2026
8-K Current report
Officer or director change, Other events
Jan 30, 2026 Jan 30, 2026
8-K Current report
Other events
Dec 19, 2025 Dec 19, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2025 Aug 12, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2025 Jun 12, 2025
8-K Current report
Regulation FD disclosure, Other events
May 28, 2025 May 28, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
8-K Current report
Officer or director change
Apr 28, 2025 Apr 22, 2025
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
8-K Current report
Listing notice
Feb 28, 2025 Feb 25, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure, Other events
Jan 10, 2025 Jan 7, 2025
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
8-K Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure, Other events
Oct 29, 2024 Oct 29, 2024
8-K Current report
Regulation FD disclosure
Sep 10, 2024 Sep 9, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2024 Aug 5, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 3, 2024 May 29, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
8-K Current report
Other events
Mar 29, 2024 Mar 29, 2024
8-K Current report
Results of operations
Mar 13, 2024 Mar 13, 2024
8-K Current report
Officer or director change
Feb 9, 2024 Feb 5, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 5, 2024 Jan 5, 2024
8-K Current report
Regulation FD disclosure, Other events
Jan 2, 2024 Jan 2, 2024
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Officer or director change, Other events
Nov 1, 2023 Oct 30, 2023
8-K/A Amended current report
Bylaw or fiscal year change, Shareholder vote results
Oct 16, 2023 Oct 5, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Oct 10, 2023 Oct 5, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
8-K Current report
Regulation FD disclosure, Other events
Jul 31, 2023 Jul 31, 2023
8-K Current report
Officer or director change, Other events
Jun 14, 2023 Jun 12, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Results of operations
Mar 30, 2023 Mar 30, 2023
8-K Current report
Officer or director change
Feb 1, 2023 Jan 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Other events
Nov 8, 2022 Nov 8, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 22, 2022 Sep 21, 2022
8-K Current report
Officer or director change, Shareholder vote results
Sep 19, 2022 Sep 15, 2022
8-K Current report
Other events
Sep 6, 2022 Sep 6, 2022
8-K Current report
Results of operations
Aug 10, 2022 Aug 10, 2022
8-K Current report
Officer or director change
Jul 1, 2022 Jul 1, 2022
8-K Current report
Other events
Jun 27, 2022 Jun 27, 2022
8-K Current report
Agreement ended
Jun 7, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
May 3, 2022 May 3, 2022
8-K Current report
Other events
Apr 7, 2022 Apr 6, 2022
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
8-K Current report
Other events
Feb 16, 2022 Feb 16, 2022
8-K Current report
Regulation FD disclosure, Other events
Jan 25, 2022 Jan 25, 2022
8-K Current report
Other events
Jan 19, 2022 Jan 19, 2022
8-K Current report
Other events
Jan 4, 2022 Jan 3, 2022
8-K Current report
Results of operations
Nov 10, 2021 Nov 10, 2021
8-K Current report
Regulation FD disclosure, Other events
Oct 28, 2021 Oct 27, 2021
8-K Current report
Officer or director change
Oct 12, 2021 Oct 11, 2021
8-K Current report
Material agreement, New debt
Sep 30, 2021 Sep 29, 2021
8-K Current report
Officer or director change
Aug 30, 2021 Aug 26, 2021
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Aug 18, 2021 Aug 17, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
8-K Current report
Material agreement, Unregistered share sale
Jul 1, 2021 Jun 30, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
8-K Current report
Results of operations
Mar 11, 2021 Mar 11, 2021
8-K Current report
Other events
Feb 5, 2021 Feb 5, 2021
8-K Current report
Material agreement
Jan 19, 2021 Jan 15, 2021
8-K Current report
Officer or director change, Other events
Dec 17, 2020 Dec 9, 2020
8-K Current report
Regulation FD disclosure, Other events
Dec 3, 2020 Dec 3, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Shareholder vote results
Oct 28, 2020 Oct 27, 2020
8-K Current report
Regulation FD disclosure
Sep 16, 2020 Sep 16, 2020
8-K Current report
Material agreement, Bylaw or fiscal year change, Other events
Sep 14, 2020 Sep 10, 2020
8-K Current report
Other events
Sep 9, 2020 Sep 9, 2020
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2020 Sep 8, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2020 Jun 4, 2020
8-K/A Amended current report
Officer or director change
May 11, 2020 Apr 16, 2020
8-K Current report
Results of operations
May 8, 2020 May 8, 2020
8-K Current report
Officer or director change
Apr 16, 2020 Apr 16, 2020
8-K Current report
Results of operations
Mar 16, 2020 Mar 16, 2020
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Feb 28, 2020 Feb 28, 2020
8-K Current report
Results of operations, Other events
Feb 11, 2020 Feb 11, 2020
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 30, 2020 Jan 30, 2020
8-K Current report
Material agreement, New debt
Dec 19, 2019 Dec 16, 2019
8-K Current report
Regulation FD disclosure
Dec 5, 2019 Dec 5, 2019
8-K Current report
Results of operations
Nov 4, 2019 Nov 4, 2019
8-K Current report
Regulation FD disclosure
Oct 3, 2019 Oct 3, 2019
8-K Current report
Officer or director change
Sep 6, 2019 Sep 4, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Material agreement
Jun 13, 2019 Jun 12, 2019
8-K Current report
Shareholder vote results
Jun 6, 2019 Jun 5, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
8-K Current report
Officer or director change
Apr 18, 2019 Apr 18, 2019
8-K/A Amended current report
Officer or director change
Mar 29, 2019 Mar 19, 2019
8-K Current report
Officer or director change
Mar 19, 2019 Mar 19, 2019
8-K Current report
Results of operations
Mar 14, 2019 Mar 14, 2019
8-K Current report
Material agreement, Other events
Jan 7, 2019 Jan 4, 2019
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
Nov 16, 2018 Nov 15, 2018
8-K Current report
Regulation FD disclosure, Other events
Nov 13, 2018 Nov 13, 2018
8-K Current report
Results of operations
Nov 8, 2018 Nov 8, 2018
8-K Current report
Regulation FD disclosure
Sep 27, 2018 Sep 27, 2018
8-K Current report
Officer or director change
Aug 14, 2018 Aug 14, 2018
8-K Current report
Results of operations
Aug 9, 2018 Aug 9, 2018
8-K Current report
Bylaw or fiscal year change
Jul 17, 2018 Jul 17, 2018
8-K Current report
Other events
Jul 16, 2018 Jul 16, 2018
8-K Current report
Results of operations, Other events
Jul 9, 2018 Jul 9, 2018
8-K Current report
Regulation FD disclosure
Jul 9, 2018 Jul 9, 2018
8-K Current report
Shareholder vote results
Jun 8, 2018 Jun 5, 2018
8-K Current report
Results of operations
May 10, 2018 May 10, 2018
8-K Current report
Results of operations
Apr 2, 2018 Apr 2, 2018
8-K Current report
Officer or director change
Feb 1, 2018 Feb 1, 2018
8-K Current report
Material agreement, New debt
Jan 23, 2018 Jan 17, 2018
8-K Current report
Results of operations
Dec 14, 2017 Dec 14, 2017
8-K Current report
Officer or director change, Bylaw or fiscal year change, Other events
Nov 6, 2017 Nov 6, 2017

Showing 119 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SPRO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cambridge, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1701108
Former names
Spero Therapeutics, LLC (until Mar 21, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.